Pouzin, Clemence http://orcid.org/0000-0003-3081-8201
Gibiansky, Leonid
Fagniez, Nathalie
Chadjaa, Mustapha
Tod, Michel
Nguyen, Laurent
Funding for this research was provided by:
Sanofi Genzyme (Sanofi Genzyme)
Article History
Received: 1 September 2021
Accepted: 20 December 2021
First Online: 15 February 2022
Declarations
:
: C.P., N.F., M.C. and L.N. are full-time employees and shareholders of Sanofi. L.G. is an expert scientist in pharmacometrics at QuantPharma LLC, consulting for Sanofi. M.T. is an expert scientist in pharmacometrics at University of Claude Bernard Lyon 1, consulting for Sanofi.
: All patients enrolled in the TED13751 study provided written informed consent to participate. No identifying information for individual patients is included in this article.
: The TED13751 study was approved by the Medical Ethics Committee and conducted in accordance with the International Conference on Harmonization guidelines for Good Clinical Practice.